Active	Status	Sponsor type	Region	Phase	Filter
6 Active 3 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Buhl, Roland
NCT06035289: Register Schweres Asthma - German Asthma Net e.V.	Recruiting	N/A	4500	Europe		German Asthma Net e.V., AstraZeneca, GlaxoSmithKline, Sanofi, Chiesi Farmaceutici S.p.A.	Severe Asthma	11/26	11/26
Neurohr, Claus
FGCL-3019-095, NCT04419558 / 2020-000697-22: Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Apr 2024 - Sep 2024: Topline data from ZEPHYRUS-2 trial for IPF	Terminated	3	372	Europe, US, RoW	Pamrevlumab, FG-3019, Placebo	FibroGen	Idiopathic Pulmonary Fibrosis	09/23	09/23
NCT06317285: A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)	Recruiting	2	150	Europe, Canada, US, RoW	GSK3915393, Placebo	GlaxoSmithKline	Idiopathic Pulmonary Fibrosis	03/26	03/26
NCT03318406: Post-Market BTVA Registry	Recruiting	N/A	300	Europe	Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor	Uptake Medical Technology, Inc.	Emphysema or COPD	12/27	12/30
NCT05717192: BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation	Recruiting	N/A	224	Europe	InterVapor®-System	IHF GmbH - Institut für Herzinfarktforschung	Emphysema or Chronic Obstructive Pulmonary Disease	04/26	12/27
NCT06035289: Register Schweres Asthma - German Asthma Net e.V.	Recruiting	N/A	4500	Europe		German Asthma Net e.V., AstraZeneca, GlaxoSmithKline, Sanofi, Chiesi Farmaceutici S.p.A.	Severe Asthma	11/26	11/26